(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IGFBP4 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:10775 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP4 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:10775 6480464 vinylidene chloride results in decreased expression of IGFBP4 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:10775 6480464 1, 2-Dimethylhydrazine results in increased expression of IGFBP4 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:10775 6480464 Ethinyl Estradiol affects the expression of IGFBP4 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IGFBP4 mRNA CTD PMID:17108234 17alpha-ethynylestradiol increases expression ISO RGD:69043 6480464 Ethinyl Estradiol results in increased expression of IGFBP4 protein CTD PMID:15817916 17beta-estradiol affects expression ISO RGD:69043 6480464 Estradiol affects the expression of IGFBP4 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:69043 6480464 Estradiol results in increased expression of IGFBP4 mRNA CTD PMID:14605097 more ... 17beta-estradiol increases expression ISO RGD:10775 6480464 Estradiol results in increased expression of IGFBP4 mRNA CTD PMID:12469912 17beta-estradiol multiple interactions ISO RGD:69043 6480464 [Cycloheximide co-treated with Estradiol] results in increased expression of IGFBP4 mRNA more ... CTD PMID:12399409 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69043 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP4 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP4 mRNA CTD PMID:23639626 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP4 protein] more ... CTD PMID:23639626 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69043 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP4 mRNA CTD PMID:21496263 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10775 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP4 mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10775 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP4 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10775 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP4 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69043 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP4 mRNA CTD PMID:19901195 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:10775 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP4 mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:10775 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IGFBP4 mRNA CTD PMID:18200517 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:10775 6480464 Glucosamine results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 2-butoxyethanol decreases expression ISO RGD:10775 6480464 n-butoxyethanol results in decreased expression of IGFBP4 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:10775 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10775 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of IGFBP4 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of IGFBP4 mRNA CTD PMID:28522335 3-Nitrobenzanthrone increases expression ISO RGD:69043 6480464 3-nitrobenzanthrone results in increased expression of IGFBP4 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:10775 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of IGFBP4 mRNA CTD PMID:30951980 5-azacytidine increases expression ISO RGD:69043 6480464 Azacitidine results in increased expression of IGFBP4 mRNA CTD PMID:20823114 5-fluorouracil multiple interactions ISO RGD:69043 6480464 IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of IGFBP4 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of IGFBP4 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:69043 6480464 Acrylamide results in decreased expression of IGFBP4 mRNA CTD PMID:32763439 afimoxifene multiple interactions ISO RGD:69043 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of IGFBP4 mRNA] CTD PMID:21233418 afimoxifene increases expression ISO RGD:69043 6480464 afimoxifene results in increased expression of IGFBP4 mRNA CTD PMID:15072547 , PMID:19901195 aflatoxin B1 affects expression ISO RGD:69043 6480464 Aflatoxin B1 affects the expression of IGFBP4 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:69043 6480464 Aflatoxin B1 results in increased expression of IGFBP4 mRNA CTD PMID:21632981 aflatoxin B1 increases expression ISO RGD:10775 6480464 Aflatoxin B1 results in increased expression of IGFBP4 mRNA CTD PMID:19770486 aldehydo-D-glucosamine decreases expression ISO RGD:10775 6480464 Glucosamine results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 aldehydo-D-glucose decreases expression ISO RGD:10775 6480464 Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 all-trans-retinoic acid multiple interactions ISO RGD:69043 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of IGFBP4 mRNA CTD PMID:15894607 all-trans-retinoic acid decreases expression ISO RGD:69043 6480464 Tretinoin results in decreased expression of IGFBP4 mRNA CTD PMID:15894607 , PMID:33167477 alpha-naphthoflavone multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein] CTD PMID:23639626 alpha-naphthoflavone increases expression EXP 6480464 alpha-naphthoflavone results in increased expression of IGFBP4 protein CTD PMID:23639626 aluminium sulfate (anhydrous) decreases secretion ISO RGD:69043 6480464 aluminum sulfate results in decreased secretion of IGFBP4 protein CTD PMID:7685579 aluminium trifluoride decreases expression ISO RGD:69043 6480464 aluminum fluoride results in decreased expression of IGFBP4 mRNA, aluminum fluoride results in decreased expression of IGFBP4 protein CTD PMID:11996908 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP4 mRNA CTD PMID:16483693 arsenite(3-) multiple interactions ISO RGD:69043 6480464 Fulvestrant inhibits the reaction [arsenite results in increased expression of IGFBP4 mRNA] CTD PMID:31646340 arsenite(3-) increases expression ISO RGD:69043 6480464 arsenite results in increased expression of IGFBP4 mRNA CTD PMID:31646340 arsenous acid multiple interactions ISO RGD:69043 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP4 protein, [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of IGFBP4 mRNA CTD PMID:15894607 , PMID:27430728 arsenous acid increases expression ISO RGD:69043 6480464 Arsenic Trioxide results in increased expression of IGFBP4 protein CTD PMID:27430728 atrazine increases expression ISO RGD:69043 6480464 Atrazine results in increased expression of IGFBP4 mRNA CTD PMID:22378314 azoxystrobin decreases expression ISO RGD:69043 6480464 azoxystrobin results in decreased expression of IGFBP4 mRNA CTD PMID:33512557 benzo[a]pyrene affects expression ISO RGD:69043 6480464 Benzo(a)pyrene affects the expression of IGFBP4 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression ISO RGD:69043 6480464 Benzo(a)pyrene results in decreased expression of IGFBP4 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:69043 6480464 Benzo(a)pyrene results in increased methylation of IGFBP4 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:69043 6480464 Benzo(a)pyrene results in increased expression of IGFBP4 mRNA CTD PMID:21632981 benzo[a]pyrene increases expression ISO RGD:10775 6480464 Benzo(a)pyrene results in increased expression of IGFBP4 mRNA CTD PMID:20713471 , PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:10775 6480464 Benzo(a)pyrene results in decreased expression of IGFBP4 mRNA CTD PMID:19770486 , PMID:21715664 benzo[b]fluoranthene decreases expression ISO RGD:10775 6480464 benzo(b)fluoranthene results in decreased expression of IGFBP4 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression ISO RGD:10775 6480464 Glucosamine results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP4 mRNA CTD PMID:10604720 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69043 6480464 Diethylhexyl Phthalate results in increased expression of IGFBP4 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10775 6480464 Diethylhexyl Phthalate results in decreased expression of IGFBP4 mRNA CTD PMID:31211961 bisphenol A increases expression ISO RGD:69043 6480464 bisphenol A results in increased expression of IGFBP4 mRNA CTD PMID:16474171 , PMID:21826169 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP4 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:10775 6480464 bisphenol A results in increased expression of IGFBP4 mRNA CTD PMID:30951980 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IGFBP4 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:69043 6480464 bisphenol A results in decreased expression of IGFBP4 mRNA CTD PMID:25047013 bisphenol F increases expression ISO RGD:10775 6480464 bisphenol F results in increased expression of IGFBP4 mRNA CTD PMID:30951980 bucladesine multiple interactions ISO RGD:69043 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP4 mRNA CTD PMID:20823114 butyric acid increases expression ISO RGD:69043 6480464 Butyric Acid results in increased expression of IGFBP4 mRNA CTD PMID:34581912 cadmium atom increases expression ISO RGD:69043 6480464 Cadmium results in increased expression of IGFBP4 mRNA CTD PMID:21120746 , PMID:31646340 cadmium atom multiple interactions ISO RGD:69043 6480464 Fulvestrant inhibits the reaction [Cadmium results in increased expression of IGFBP4 mRNA] CTD PMID:31646340 cadmium dichloride multiple interactions ISO RGD:69043 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of IGFBP4 protein] CTD PMID:26138014 cadmium dichloride decreases secretion ISO RGD:69043 6480464 Cadmium Chloride results in decreased secretion of IGFBP4 protein CTD PMID:26138014 calciol increases expression ISO RGD:10775 6480464 Cholecalciferol results in increased expression of IGFBP4 mRNA CTD PMID:17170073 cannabidiol decreases expression ISO RGD:10775 6480464 Cannabidiol results in decreased expression of IGFBP4 mRNA CTD PMID:21542829 cannabidiol multiple interactions ISO RGD:10775 6480464 Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IGFBP4 mRNA] CTD PMID:27256343 carbon nanotube increases expression ISO RGD:10775 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:69043 6480464 CGP 52608 promotes the reaction [RORA protein binds to IGFBP4 gene] CTD PMID:28238834 ciguatoxin CTX1B affects expression ISO RGD:10775 6480464 Ciguatoxins affects the expression of IGFBP4 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:69043 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of IGFBP4 mRNA CTD PMID:30871063 cisplatin decreases expression ISO RGD:69043 6480464 Cisplatin results in decreased expression of IGFBP4 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:10775 6480464 Cisplatin results in decreased expression of IGFBP4 mRNA CTD PMID:21151649 clofibrate decreases expression ISO RGD:10775 6480464 Clofibrate results in decreased expression of IGFBP4 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:69043 6480464 cobaltous chloride results in decreased expression of IGFBP4 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of IGFBP4 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:69043 6480464 Copper Sulfate results in increased expression of IGFBP4 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:69043 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 cumene multiple interactions ISO RGD:10775 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of IGFBP4 mRNA CTD PMID:18648096 curcumin multiple interactions ISO RGD:10775 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP4 mRNA] CTD PMID:18200517 curcumin multiple interactions ISO RGD:69043 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of IGFBP4 protein CTD PMID:27430728 cycloheximide increases expression ISO RGD:69043 6480464 Cycloheximide results in increased expression of IGFBP4 mRNA CTD PMID:15072547 cycloheximide multiple interactions ISO RGD:69043 6480464 [Cycloheximide co-treated with Estradiol] results in increased expression of IGFBP4 mRNA CTD PMID:15072547 cyclophosphamide multiple interactions ISO RGD:69043 6480464 IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 cyclosporin A increases expression ISO RGD:69043 6480464 Cyclosporine results in increased expression of IGFBP4 mRNA CTD PMID:21632981 D-glucose decreases expression ISO RGD:10775 6480464 Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 daidzein increases expression ISO RGD:69043 6480464 daidzein results in increased expression of IGFBP4 mRNA CTD PMID:15757668 decabromodiphenyl ether affects expression ISO RGD:69043 6480464 decabromobiphenyl ether affects the expression of IGFBP4 mRNA CTD PMID:24834073 dexamethasone decreases expression ISO RGD:10775 6480464 Dexamethasone results in decreased expression of IGFBP4 mRNA CTD PMID:22733784 dextran sulfate multiple interactions ISO RGD:10775 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP4 mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions ISO RGD:69043 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP4 protein, [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of IGFBP4 mRNA CTD PMID:15894607 , PMID:27430728 diarsenic trioxide increases expression ISO RGD:69043 6480464 Arsenic Trioxide results in increased expression of IGFBP4 protein CTD PMID:27430728 dibenzo[a,l]pyrene increases expression ISO RGD:10775 6480464 dibenzo(a, l)pyrene results in increased expression of IGFBP4 mRNA CTD PMID:25908611 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP4 mRNA CTD PMID:17005392 dioxygen multiple interactions ISO RGD:10775 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of IGFBP4 mRNA more ... CTD PMID:25922074 , PMID:30529165 doxorubicin multiple interactions ISO RGD:69043 6480464 IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 doxorubicin increases expression ISO RGD:69043 6480464 Doxorubicin results in increased expression of IGFBP4 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:69043 6480464 Selenium results in increased expression of IGFBP4 mRNA CTD PMID:19244175 ellagic acid decreases expression ISO RGD:69043 6480464 Ellagic Acid results in decreased expression of IGFBP4 mRNA CTD PMID:12002526 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of IGFBP4 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:69043 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA CTD PMID:19167446 ethanol affects splicing ISO RGD:10775 6480464 Ethanol affects the splicing of IGFBP4 mRNA CTD PMID:30319688 flutamide increases expression EXP 6480464 Flutamide results in increased expression of IGFBP4 mRNA CTD PMID:21525395 , PMID:26485406 formaldehyde increases expression ISO RGD:69043 6480464 Formaldehyde results in increased expression of IGFBP4 mRNA CTD PMID:18045764 fulvestrant decreases expression ISO RGD:69043 6480464 Fulvestrant results in decreased expression of IGFBP4 mRNA CTD PMID:15072547 , PMID:31646340 fulvestrant multiple interactions ISO RGD:69043 6480464 Fulvestrant inhibits the reaction [arsenite results in increased expression of IGFBP4 mRNA] more ... CTD PMID:31646340 genistein increases expression ISO RGD:69043 6480464 Genistein results in increased expression of IGFBP4 mRNA CTD PMID:15757668 more ... glucose decreases expression ISO RGD:10775 6480464 Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 hydrogen peroxide increases expression ISO RGD:69043 6480464 Hydrogen Peroxide results in increased expression of IGFBP4 mRNA CTD PMID:32949572 inulin multiple interactions ISO RGD:10775 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP4 mRNA CTD PMID:36331819 isotretinoin increases expression ISO RGD:69043 6480464 Isotretinoin results in increased expression of IGFBP4 mRNA CTD PMID:20436886 leflunomide increases expression ISO RGD:69043 6480464 leflunomide results in increased expression of IGFBP4 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:69043 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of IGFBP4 mRNA more ... CTD PMID:35811015 , PMID:35877022 medroxyprogesterone acetate multiple interactions ISO RGD:69043 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP4 mRNA CTD PMID:20823114 methidathion increases expression ISO RGD:10775 6480464 methidathion results in increased expression of IGFBP4 mRNA CTD PMID:34813904 methotrexate decreases expression ISO RGD:69043 6480464 Methotrexate results in decreased expression of IGFBP4 mRNA CTD PMID:24449571 N(6)-methyladenosine multiple interactions ISO RGD:69043 6480464 [[METTL3 protein affects the abundance of N-methyladenosine] which affects the methylation of IGFBP4 mRNA] which affects the expression of IGFBP4 protein more ... CTD PMID:35971034 N-acetyl-L-cysteine multiple interactions ISO RGD:69043 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of IGFBP4 protein] CTD PMID:26138014 N-nitrosodiethylamine increases expression ISO RGD:69043 6480464 Diethylnitrosamine results in increased expression of IGFBP4 mRNA CTD PMID:21527772 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of IGFBP4 mRNA CTD PMID:24136188 nickel dichloride decreases expression ISO RGD:10775 6480464 nickel chloride results in decreased expression of IGFBP4 mRNA CTD PMID:12839937 nickel sulfate decreases expression ISO RGD:69043 6480464 nickel sulfate results in decreased expression of IGFBP4 mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of IGFBP4 mRNA, nitrofen results in increased expression of IGFBP4 protein CTD PMID:20938897 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of IGFBP4 mRNA CTD PMID:18417182 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP4 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of IGFBP4 mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression ISO RGD:69043 6480464 Menthol results in decreased expression of IGFBP4 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:69043 6480464 IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 paclitaxel increases expression ISO RGD:69043 6480464 Paclitaxel results in increased expression of IGFBP4 mRNA CTD PMID:19682730 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IGFBP4 mRNA CTD PMID:33387578 parathion increases expression ISO RGD:10775 6480464 Parathion results in increased expression of IGFBP4 mRNA CTD PMID:34813904 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of IGFBP4 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10775 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP4 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid multiple interactions ISO RGD:69043 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IGFBP4 mRNA CTD PMID:33325755 phenylephrine affects response to substance EXP 6480464 IGFBP4 protein affects the susceptibility to Phenylephrine CTD PMID:11159833 phytoestrogen multiple interactions ISO RGD:69043 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IGFBP4 mRNA CTD PMID:33325755 picoxystrobin decreases expression ISO RGD:69043 6480464 picoxystrobin results in decreased expression of IGFBP4 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:10775 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of IGFBP4 mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of IGFBP4 mRNA] CTD PMID:20059764 , PMID:20813756 pirinixic acid decreases expression ISO RGD:10775 6480464 pirinixic acid results in decreased expression of IGFBP4 mRNA CTD PMID:20059764 more ... potassium chloride affects response to substance EXP 6480464 IGFBP4 protein affects the susceptibility to Potassium Chloride CTD PMID:11159833 potassium chromate decreases expression ISO RGD:69043 6480464 potassium chromate(VI) results in decreased expression of IGFBP4 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:69043 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP4 mRNA CTD PMID:20660070 pyrimidifen increases expression ISO RGD:69043 6480464 pyrimidifen results in increased expression of IGFBP4 mRNA CTD PMID:33512557 quercetin increases expression ISO RGD:69043 6480464 Quercetin results in increased expression of IGFBP4 mRNA CTD PMID:21632981 raloxifene affects expression ISO RGD:69043 6480464 Raloxifene Hydrochloride affects the expression of IGFBP4 mRNA CTD PMID:14699072 resveratrol multiple interactions ISO RGD:69043 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP4 mRNA more ... CTD PMID:16338976 , PMID:23557933 resveratrol decreases expression ISO RGD:69043 6480464 resveratrol results in decreased expression of IGFBP4 mRNA CTD PMID:23224687 rifampicin multiple interactions ISO RGD:69043 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP4 mRNA CTD PMID:21127053 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IGFBP4 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69043 6480464 [S-(1 more ... CTD PMID:35811015 Salinomycin decreases expression ISO RGD:69043 6480464 salinomycin results in decreased expression of IGFBP4 mRNA CTD PMID:19682730 selenium atom increases expression ISO RGD:69043 6480464 Selenium results in increased expression of IGFBP4 mRNA CTD PMID:19244175 senecionine decreases expression ISO RGD:10775 6480464 senecionine results in decreased expression of IGFBP4 protein CTD PMID:35357534 sodium arsenite decreases expression ISO RGD:69043 6480464 sodium arsenite results in decreased expression of IGFBP4 mRNA CTD PMID:29301061 sodium dichromate decreases expression ISO RGD:10775 6480464 sodium bichromate results in decreased expression of IGFBP4 mRNA CTD PMID:22561333 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of IGFBP4 mRNA CTD PMID:22561333 succimer multiple interactions ISO RGD:10775 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGFBP4 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP4 mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane multiple interactions ISO RGD:10775 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of IGFBP4 mRNA CTD PMID:30529165 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of IGFBP4 mRNA CTD PMID:26141394 tamoxifen affects expression ISO RGD:69043 6480464 Tamoxifen affects the expression of IGFBP4 mRNA CTD PMID:14699072 tamoxifen affects expression ISO RGD:10775 6480464 Tamoxifen affects the expression of IGFBP4 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:69043 6480464 tert-Butylhydroperoxide results in increased expression of IGFBP4 mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO RGD:10775 6480464 Carbon Tetrachloride affects the expression of IGFBP4 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IGFBP4 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IGFBP4 mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:10775 6480464 Thapsigargin results in decreased expression of IGFBP4 protein CTD PMID:24648495 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP4 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:10775 6480464 titanium dioxide results in decreased expression of IGFBP4 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:10775 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP4 mRNA CTD PMID:29950665 topotecan increases expression EXP 6480464 Topotecan results in increased expression of IGFBP4 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP4 mRNA CTD PMID:25729387 Triptolide decreases expression ISO RGD:10775 6480464 triptolide results in decreased expression of IGFBP4 mRNA CTD PMID:32835833 triptonide decreases expression ISO RGD:10775 6480464 triptonide results in decreased expression of IGFBP4 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:69043 6480464 tris(2-butoxyethyl) phosphate affects the expression of IGFBP4 mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:10775 6480464 troglitazone results in increased expression of IGFBP4 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:10775 6480464 Tungsten results in decreased expression of IGFBP4 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:69043 6480464 Valproic Acid affects the expression of IGFBP4 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:10775 6480464 Valproic Acid results in increased expression of IGFBP4 mRNA CTD PMID:24896083 valproic acid decreases expression ISO RGD:69043 6480464 Valproic Acid results in decreased expression of IGFBP4 mRNA CTD PMID:29154799 vanadium atom decreases expression ISO RGD:69043 6480464 Vanadium results in decreased expression of IGFBP4 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:69043 6480464 Vanadium results in decreased expression of IGFBP4 mRNA CTD PMID:19000753 vitamin E increases expression ISO RGD:69043 6480464 Vitamin E results in increased expression of IGFBP4 mRNA CTD PMID:19244175 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP4 protein CTD PMID:10985758 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP4 protein CTD PMID:10985758